RVNC +42%/PM on phase-2 results in BELMONT study of RT002-vs-Botox in glabellar lines: Press release: http://finance.yahoo.com/news/revance-reports-positive-6-month-110000898.html CC slides: http://investors.revance.com/common/download/download.cfm?companyid=AMDA-2GNRV0&fileid=857315&filekey=FC9A9B86-E0AC-461A-B5CD-82DA5C466025&filename=BELMONT_24-Week_Interim_Result_Slide_Presentation_II.pdf Link to CC replay: http://edge.media-server.com/m/p/ygpiygdr